[EN] TARGETED DELIVERY TO BETA CELLS<br/>[FR] ADMINISTRATION CIBLÉE À DES CELLULES BÊTA
申请人:CHOUDHARY AMIT
公开号:WO2018195486A1
公开(公告)日:2018-10-25
The disclosure includes zinc prodrugs for targeted delivery of therapeutic, diagnostic or imaging agents to β-cells and methods of use therefor. The disclosure also includes targeted delivery of small molecules to β-cells that stabilize and activate CRISPR effector proteins comprising at least one destabilization domain, to enable CRISPR-based genome editing and transcriptional activation or repression in β-cells.
Coordination complexes for detecting analytes, and methods of making and using the same
申请人:——
公开号:US20030068275A1
公开(公告)日:2003-04-10
The present invention is directed, in part, to coordination complexes for detecting analytes, and methods of making and using the same.
本发明部分涉及用于检测分析物的配位络合物,以及制备和使用该配位络合物的方法。
PROCESS FOR PRODUCING ALKANOLAMINE
申请人:NIPPON SHOKUBAI CO., LTD.
公开号:US20190039997A1
公开(公告)日:2019-02-07
The present invention provides a method of producing an ethanolamine, with a low production ratio of a dialkanolamine (for example, less than 30% by weight). A process for producing an alkanolamine of the present invention includes reacting an alkylene oxide with ammonia to obtain a reaction product containing a monoalkanolamine, a dialkanolamine, and a trialkanolamine; separating the dialkanolamine from the reaction product; and recycling at least a portion of the dialkanolamine for the reaction of an alkylene oxide with ammonia, wherein in the recycling step, the dialkanolamine is supplied in a molar ratio of the alkylene oxide (moles) to a total amount (moles) of ammonia and the dialkanolamine of 0.08 or more and less than 0.26.